Sana Biotechnology Stock Today
| SANA Stock | USD 2.25 0.09 3.85% |
PerformanceModest
| Odds Of DistressHigh
|
Sana Biotechnology is trading at 2.25 as of the 20th of March 2025, a 3.85 percent decrease since the beginning of the trading day. The stock's open price was 2.34. Sana Biotechnology has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company was incorporated in 2018 and is headquartered in Seattle, Washington. Sana Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 225.02 M outstanding shares of which 44.33 M shares are at this time shorted by private and institutional investors with about 14.01 trading days to cover. More on Sana Biotechnology
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sana Stock Highlights
| CEO President | Steven MD |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Sana Biotechnology (SANA) is traded on NASDAQ Exchange in USA. It is located in 188 East Blaine Street, Seattle, WA, United States, 98102 and employs 328 people. Sana Biotechnology is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 618.45 M. Sana Biotechnology conducts business under Biotechnology sector and is part of Health Care industry. The entity has 225.02 M outstanding shares of which 44.33 M shares are at this time shorted by private and institutional investors with about 14.01 trading days to cover.
Sana Biotechnology currently holds about 484.8 M in cash with (223.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sana Biotechnology Probability Of Bankruptcy
Ownership AllocationSana Biotechnology shows a total of 225.02 Million outstanding shares. The majority of Sana Biotechnology outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Sana Biotechnology to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Sana Biotechnology. Please pay attention to any change in the institutional holdings of Sana Biotechnology as this could imply that something significant has changed or is about to change at the company. Also note that roughly five million one hundred thirty thousand five hundred seventy invesors are currently shorting Sana Biotechnology expressing very little confidence in its future performance.
Check Sana Ownership Details
Sana Biotechnology Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sana Biotechnology market risk premium is the additional return an investor will receive from holding Sana Biotechnology long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.086 | |||
| Jensen Alpha | 1.71 | |||
| Total Risk Alpha | 3.72 | |||
| Sortino Ratio | 0.2739 |
Sana Stock Against Markets
Sana Biotechnology Corporate Management
| Sunil MD | Head VP | Profile | |
| Christian MBA | Executive Officer | Profile | |
| Shanna Peek | Sr Operations | Profile | |
| Richard Mulligan | Executive Research | Profile | |
| Sonja MD | Senior Platform | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sana Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sana Biotechnology. If investors know Sana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sana Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sana Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.